
1260-Prostate Cancer: Genomic Landscape & Precision Therapy
This paper provides a comprehensive analysis of the genomic landscape and precision medicine strategies currently reshaping prostate cancer management. The text highlights how molecular profiling has identified critical drivers of disease progression, such as androgen receptor signaling, DNA damage repair mutations, and lineage plasticity. These biological insights are enabling the transition from standardized treatments to individualized therapies, including PARP inhibitors, radioligand treatments, and immune checkpoint blockades. Despite these clinical improvements, the authors emphasize…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.